Øyceletransplantasjon. Eksperimentelt og klinisk forskningsprogram for å optimalisere transplantasjon av insulinproduserende vev som behandling for type 1 diabetes
- Prosjektnummer
- 3b-170
- Ansvarlig person
- Aksel Foss, dr.med
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Metabolic and Endocrine
- Forskningsaktivitet
- 5. Treatment Developement
The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.
Diabetologia 2009 Jul;52(7):1352-62. Epub 2009 mai 5
PMID: 19415233
Vitacyte collagenase HA: a novel enzyme blend for efficient human islet isolation.
Transplantation 2009 Dec;88(12):1400-2.
PMID: 20029339
Positron emission tomography in clinical islet transplantation.
Am J Transplant 2009 Dec;9(12):2816-24. Epub 2009 okt 21
PMID: 19845588
Large-scale comparison of Liberase HI and collagenase NB1 utilized for human islet isolation.
Cell Transplant 2010;19(1):3-8. Epub 2009 okt 9
PMID: 19818208
The importance of tryptic-like activity in purified enzyme blends for efficient islet isolation.
Transplantation 2009 Feb;87(3):370-5.
PMID: 19202441
Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo.
Transpl Int 2008 Jul;21(7):669-78. Epub 2008 mar 13
PMID: 18346012
Intramuscular islet transplantation: a proof of principle in a syngeneic rat model
Abstract: STS XXIV Congress May 14-16 2008. Transplant Proc. in press
Liver x receptor agonist (GW3965) inhibits tissue factor expression and improves viability in human islets in vitro
Abstract: STS XXIV Congress May 14-16 2008. Transplant Proc. in press
Effects of Exendin-4 on human and murine islets in vitro
Abstract: STS XXIV Congress May 14-16 2008. Transplant Proc. in press
Stamceller
Patetra 2007; 1: 22-25
Stamceller
www.lommelegen.no 27.03.2007
Exendin-4 reduces inflammation and preserves viability in human and murine islets in vitro
CTS-IPITA-IXA 2007 Joint Conference - Abstract no PJ1034
Strategies to counteract ß-cell loss in pancreatic islet transplantation
- Disputert:
- november 2009
- Hovedveileder:
- Aksel Foss
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport